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Background: 2q37 deletion syndrome is a rare congenital disorder that is characterized by facial dysmorphism,
obesity, vascular and skeletal malformations, and a variable degree of intellectual disability. To date, common but
variable phenotypes, such as skeletal or digit malformations and obesity, have been associated with the deleted
size or affected genes at chromosome 2q37. However, it remains elusive whether 2q37 deletion per se or other
genetic factors, such as copy number variations (CNVs), may confer the risk for the tumorigenic condition.
Case presentation: We report a two-year-old Japanese boy with 2q37 deletion syndrome who exhibited the
typical facial appearance, coarctation of the aorta, and a global developmental delay, while lacking the symptoms
of brachydactyly and obesity. He developed a sex cord-stromal tumor of the right testis at three months of age.
The array comparative genome hybridization analysis identified an 8.2-Mb deletion at 2q37.1 (chr2:234,275,216-242,
674,807) and it further revealed two additional CNVs: duplications at 1p36.33–p36.32 (chr1:834,101–2,567,832) and
20p12.3 (chr20:5,425,762–5,593,096). The quantitative PCRs confirmed the heterozygous deletion of HDAC4 at 2q37.3
and duplications of DVL1 at 1q36 and GPCPD1 at 20p12.3.
Conclusion: This study describes the unique phenotypes in a boy with 2q37 deletion and additional CNVs at
1p36.33–p36.32 and 20p12.3. The data provide evidence that the phenotypic variations and unusual complications
of 2q37 deletion syndrome are not simply explained by the deleted size or genes located at 2q37, but that external
CNVs may account at least in part for their variant phenotypes. Accumulating the CNV data for chromosomal
disorders will be beneficial for understanding the genetic effects of concurrent CNVs on the syndromic phenotypes
and rare complications.
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2q37 deletion (del2q37) syndrome is a rare chromosomal
disorder that is characterized by congenital hypotonia,
cardiovascular anomalies, and mild to severe develop-
mental delays [1-8]. The characteristic facial appearance
includes a prominent forehead, sparse hair, highly arched
eyebrows, deep-set eyes, a flat nasal bridge, a thin upper
lip, and minor ear abnormalities [3]. To date, common
but variable phenotypes, such as skeletal or digit malfor-
mations and obesity, have been associated with the de-
leted size or affected genes at 2q37 [1,3,5-7]; however, it* Correspondence: ysakai22q13@gmail.com
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reproduction in any medium, provided the orremains unknown whether the segmental loss of 2q37 by
itself or additional risk factors may contribute to the de-
velopment of these phenotypes [2,3,9-13]. In this report,
we describe the complication of testicular sex cord-stromal
tumor as a novel complication of del2q37 syndrome. This
study provides a new line of evidence for the presence of
diverse genetic backgrounds in rare chromosomal disor-
ders. This finding also supports the theory of multiple
copy number variations (CNVs) as a phenotypic modifier
of neuro-developmental diseases [10,14].
Materials and methods
This study was approved by the institutional review
board at Kyushu University (#461-00) and conducted in
stringent compliance to the guidelines for genetic andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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from the parents for publication of this case report and
any accompanying images. Array comparative genome
hybridization (CGH) was performed as previously de-
scribed [15]. Standard techniques of quantitative (q)
PCR and immunohistochemistry were used [16,17]. The
coordinates of CNV breakpoints were defined according
to the UCSC genome assembly, GRCh37/hg19 (http://
genome.ucsc.edu/). More details for these methods are
described in Additional file 1.
Case presentation
A Japanese boy was born to healthy, nonconsanguineous
parents at the 38th week of gestation, weighing 2,810 g,Figure 1 Pathological features of the testicular tumor. (A) The hemato
tumor cells that are arranged in sheet-like or focal glandular patterns (arrow
fibrous bundles (arrowheads). A magnified view is shown in the right pane
signals for vimentin (B), alpha-inhibin (C), ER (D), and AE1/AE3 (E). Arrowswithout asphyxia. Muscle hypotonia and the dysmorphic
face with sparse hair, round forehead, depressed eyes, flat
nasal bridge, and thin upper lips were evident (Additional
file 1: Figure S1A), while brachydactyly and obesity were
absent (data not shown). The G-band test determined
the karyotype as 46, XY, del (2) (q37.1) (Additional file 1:
Figure S1B). The karyotyping of his parents revealed that
the father carried 46, XY, inv (1) (p36.1p36.3) with the
breakpoint between the 1p36.1 and 1p36.3 regions (data
not shown). Neither of his parents suffered from an
intelligence disability or mental illness. He underwent
surgical resection for right testicular hypertrophy at three
months of age. Microscopic analyses disclosed the pres-
ence of a sex cord- stromal tumor (Figure 1A) and thexylin-eosin staining for the tumor depicts the oval or spindle-shaped
s). The surrounding structures accompanying the tumor cells show
l. (B–E) Immunohistochemistry for the tumor cells shows positive
indicate the cells presenting these antigens.
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inhibin, ER, and cytokeratin AE1/AE3 supported the
diagnosis (Figure 1B to E).
Results
The microarray-based CGH detected duplications at the
chromosome 1p36.33–p36.32 and 20p12.3 regions in
addition to the 8.2-Mb heterozygous deletion at 2q37
(Figure 2A). The telomeric and centromeric break points
of the del2q37 were determined to be chr2:242,522,217–
242,674,807 and chr2:234,275,216–234,264,038; those of
dup1p36.33–p36.32 were chr1:1–834,101 and chr1:2,567,
832–2,582,842; and those of dup20p12.3 were chr20:5,449,
902–5,425,762 and chr20:5,593,096–5,626,442 (Figure 2B
to D). We further mapped the genes within the intervalsFigure 2 Chromosomal microarray analysis and validation assays by q
variations in the patient DNA. The plots show the relative copy numbers (Y
represent the genomic regions with duplication and deletion, respectively.
2q37 and 20p12.3). (B–D) Magnified views and gene mapping in the CNV
and dashed vertical lines represent the maximum and minimum breakpoin
gene loci (blue diagrams) were obtained from the UCSC genome browser
GPCPD1 (D) genes. Only the genes that were selected for qPCR and DIS3L2
numbers of HDAC4, DVL1, and GPCPD1 to those of the reference genes (PS
triplicated PCR assays. *, P < 0.05 (Student’s t-test).of deleted or duplicated regions according to the
UCSC genome browser (Figure 2B to D). One of the
Wilms tumor-associated genes, DIS3L2 (chr2:232,826,
293-233,208,678) [2], was located outside of the proximal
breakpoint of our case (chr2: 234,275,216-234,264,038)
(Figure 2C). Relative copy numbers of the genes within
the structural variations at 2q37 (HDAC4), 1p36 (DVL1),
and 20p12 (GPCPD1) were calculated in comparison with
those of the reference genes (PSMD1, TP73, and MCM8)
that were selected from the flanking regions of the CNVs.
The qPCR analyses validated the heterozygous deletion of
HDAC4 at 2q37.3, the duplication of DVL1 at 1p36.33,
and the duplication of GPCPD1 at 20p12.3 (Figure 2E).
These data verified that an individual with del2q37 syn-
drome carried other genetic burdens in his genome.uantitative PCR. (A) A genome-wide scanning of copy number
-axis) against the chromosome regions (X-axis). Green and red dots
Arrows indicate the three chromosomal regions with CNVs (1p36,
regions at 1p36.33–p36.32 (B), 2q37.1–37.3 (C) and 20p12.3 (D). Solid
ts of CNVs, respectively. Chromosomal bands, genomic scale and the
(hg19). Red squares highlight the loci of the DVL1 (B), HDAC4 (C) and
are annotated for simplicity. (E) Quantitative PCR data for the copy
MD1, TP73 and MCM8). Bar plots represent mean ± SD values with
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we successfully identified the breakpoints at 2q37 for 39
individuals using FISH or CGH data in the literature
[1,2,4-8]. To gain more insight into the genotype-
phenotype correlation in individuals with del2q37 syn-
drome, we scrutinized the genetic information of the 39
previously reported cases from five studies, and we sum-
marized them as a graphic overview (Figure 3) [1,2,4-8].Figure 3 Literature overview of the deleted regions at 2q37, the conc
individuals. The horizontal blue bars indicate the deleted regions that wer
orange vertical lines denote the locations of the brachydactyly- and obesit
about the chromosomal bands, mapped genes, and bacterial artificial chro
was converted to the genomic scale of the UCSC genome browser assemb
author and the case identification (left) are annotated as described in the o
obesity are shown on the right. The clinical phenotypes are highlighted (sh
(i.e., a patient who is negative for brachydactyly or obesity despite carrying
locus information for the associated CNV is described at the right end. Not
with such atypical presentation of the phenotypes have additional CNVs thThe size of the deletion at 2q37 ranged from 1.1 to
9.9 Mb (median, 5.2 Mb). The proximal break points
greatly varied in individuals between 2q37.1 and q37.3
(chr2:232,306,614–243,026,600). Among the genes that
were affected by the 2q37 deletion, the heterozygous loss
of HDAC4 and CAPN4 have been suspected to cause bra-
chydactyly and obesity, respectively, which are the most
common clinical features of del2q37 syndrome [5]. Theomitant CNVs and the phenotypic variations of affected
e identified in individuals with 2q37 deletion syndrome. The two
y-associated genes, HDAC4 and CAPN10, respectively. The information
mosome (BAC) probe loci that was described in the original studies
ly GRCh37/hg19 and is shown at the top of the bar plots. The first
riginal articles. The presence (+) or absence (-) of brachydactyly and
aded in pink) when the phenotypes do not match the genotype
a large deletion encompassing the HDAC4 or CAPN10 locus). The brief
e that five (P9, 11, 12, 13, and this case) of the seven cases (red dots)
at are external to 2q37. NA, data not available.
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loci, but the patient did not show either of the related
phenotypes (Figure 3). Similarly, 21 out of the 40 patients
(53%) with del2q37 syndrome, including our patient,
showed neither brachydactyly nor obesity despite carry-
ing large deletions encompassing the two loci (Figure 3).
Furthermore, we found that five of seven cases that were
atypically negative for brachydactyly and obesity carried
external CNVs in addition to the 2q37 deletion (Figure 3).
These data supported the idea that the size of the dele-
tion at 2q37 and the affected genes do not always deter-
mine the phenotypic presentation of brachydactyly,
obesity, and tumorigenic complications for del2q37 syn-
drome. Instead, some additional genetic modifiers, such
as external CNVs, might contribute to the phenotypic
alterations.
Discussion
This study provides novel insight into the genotype-
phenotype correlations of the rare chromosomal dis-
order del2q37 syndrome. First, this case manifests typ-
ical clinical features of del2q37 syndrome, while the
phenotypic presentation because of the 1p36 duplication
was less evident except for intelligence disability [18].
This finding suggests that haploinsufficiency of the genes
at 2q37, rather than the segmental duplications of 1p36
or 20p12, shows dominant effects on the phenotypic
presentation. Specific gene functions of GPCPD1 and
the duplication of 20p12 remain to be clarified, struc-
tural variations at 20p14.3, wherein this gene is located,
were identified in healthy individuals of Korean ethnicity
[19]. Therefore, the 20p14.3 duplication spanning the
GPCPD1 locus was unlikely to alter the phenotype of
del2q37 syndrome and to produce the carcinogenic con-
dition. While the present case did not show profound
phenotype of intellectual disability compared to other
cases in the literature, we focused on duplication of
1p36.33–p36.32, since the the CNVs in this region was
described to confer the risk for neurodevelopmental dis-
orders, such as autism and intellectual disability [20-22].
Recent studies supported the hypothesis that the com-
plex phenotypes of developmental disorders might be as-
sociated with second or multiple-hit events in the
genome of the affected individuals [20]. In line with this
scenario, the prominent phenotype of our case might re-
sult from the combination of HDAC4 haploinsufficiency
with 1p36 duplication and/or other genetic factors that
remain to be uncovered. Notably, dishevelled 1 (DVL1),
the gene encoding the regulator of the canonical and
non-canonical Wnt pathways, was located in the dupli-
cated region of 1p36. It might be possible that the dupli-
cation of DVL1 accelerated tumor formation in our case.
Indeed, deregulated Wnt pathways and the overexpres-
sion of DVL1 were reported in various cancers [23,24].Altogether, we propose that the testicular tumor in our
case might be a phenotypic consequence of the haploin-
sufficiency of HDAC4 and the duplication of DVL1.
The human HDAC4 gene encodes a chromatin remod-
eling factor, histone deacetylase 4, which cooperatively
regulates gene expressions with other transcription fac-
tors in the physiological process of development and dif-
ferentiation of various tissues [25,26]. Haploinsufficiency
of HDAC4 has been implicated as a responsible gene for
the phenotypes of brachydactyly and developmental
delay since the gene locus (chr2:240016312-240220334)
was mapped to the deleted regions in individuals with
del2q37.3 syndrome, who presented these phenotypes
[8]. Moreover, Williams et al. clearly demonstrated that
frame-shift mutations of HDAC4 itself caused brachy-
dactyly mental retardation phenotypes [8]. The deleted
region in this study encompassed the HDAC locus,
whereas he did not show the brachydactyly at two years
of age. Given that brachydactyly and obesity is typically
absent in early childhood of those with del2q37 syn-
drome, the present case may develop such phenotypes
later in his life. It is thus likely that HDAC4 works as an
essential regulator of gene expressions both in embry-
onic and postnatal development.
Drake et al. [10] studied a series of sporadic Wilms tu-
mors and found evidence of a tumor suppressor role for
a 360-kb critical region at 2q37 encompassing the DIS3
mitotic control homolog (S. cerevisiae)-like 2 (DIS3L2)
locus. More recently, the germline mutations within the
DIS3L2 gene were identified to cause Perlman syndrome,
a congenital overgrowth syndrome that is predisposed to
Wilms tumor [2]. In this report, we verified that this
case had a heterozygous deletion of HDAC4, but not
DIS3L2 (Figures 2C and 3). DIS3L2 was therefore un-
likely to cause the testicular tumor in this case, although
it cannot be completely excluded that the DIS3L2 gene
expression was deregulated in the affected tissue. Not-
ably, elevated expression of HDAC4 is known to pro-
mote tumor formations, whereas its chemical inhibitors
and siRNA-mediated knockdown of HDAC4 are associ-
ated with regressions of cell growth [27]. Therefore, it is
unlikely that haploinsufficiency of HDAC4 contributed
per se to the testicular tumor formation in this case,
whereas there is little evidence that other genes within
the deleted region are associated with carcinogenesis.
Concerning various unknown mechanisms underlying
the unique phenotypes of this case, further genome-wide
analyses to identify the unique genetic backgrounds in
this case must be considered for future studies.
On the other hand, one could argue that testicular sex
cord-stromal tumor is coincidental just in this case un-
less other cases of 2q37 deletion syndrome with similar
complications are reported in the future. For better con-
venience in access to the clinical findings of this case,
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the open resource, DECIPHER (http://decipher.sanger.
ac.uk/). Also, since genome-wide data in this case are
limited to the conventional CGH analysis, we must
continue our efforts to identify the parental origin of ac-
companying CNVs, co-existence of single-nucleotide var-
iations and their associated epigenetic as well as signaling
effects [7] through genome-wide scans in future studies.Conclusion
In conclusion, this study raised the concept that the
clinical severity and the phenotypic variety of del2q37
syndrome may not be simply associated with the size of
the deletion or the genes in the affected region; rather,
they might also be associated with their combination
with other genetic variations, such as rare CNVs. Future
studies using genome-wide scanning techniques will
warrant the biological basis for phenotypic variations in
affected individuals.Consent
Written informed consent was obtained from the par-
ents for publication of this case report and any ac-
companying images. A copy of the written consent is
available for review by the Editor of this journal.Additional file
Additional file 1: Figue S1. The face appearance and the G-band
karyotype of the present case. (A) The facial appearance of the case at
two years of age shows sparse hair, broad forehead, arched eyebrows,
deep-set eyes with right palpebral ptosis, a flat nasal bridge, a thin upper
lip (left) as well as the mild micrognathia (right), the typical features for
2q37 deletion syndrome. (B) The G-band test shows the lymphocyte
karyotype of 46, XY, del (2) (q37.1). Chromosome 2 is squared with a blue
line, and shown as a magnified view in the upper panel. Arrow indicates
the chromosomal region with an abnormal band pattern.
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